✦ LIBER ✦

PHV12: MANAGEMENT STRATEGIES FOR RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA IN THE TREATMENT OF HEPATITIS C: CLINICAL AND ECONOMIC IMPLICATIONS

✍ Scribed by EB Devine; KV Kowdley; SD Sullivan; DL Veenstra

Book ID: 118613141
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 62 KB
Volume: 3
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)70504-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Peginterferon and Ribavirin: Implications for Clinical Efficacy in the Treatment of Chronic Hepatitis C

✍ Noureddin, Mazen; Ghany, Marc G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Epoetin alfa for the Treatment of Combin

Epoetin alfa for the Treatment of Combination Therapy–Induced Hemolytic Anemia in Patients Infected with Hepatitis C Virus

✍ Dr. Anastasia M. Rivkin; Sweta Chawla 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Clinical and Economic Implications of Ne

Clinical and Economic Implications of New Strategies for Heart Failure Management in the Managed Care Setting

✍ Sandra L. Chase; Kerry K. Pickworth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Economic and clinical effects of evaluat

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C

✍ John B Wong; Gary L Davis; John G McHutchison; Michael P Manns; Janice K Albrech 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Boceprevir and telaprevir for the treatm

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice

✍ Christophe Hézode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Response-guided peg-interferon plus riba

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

✍ Vincent Di Martino; Carine Richou; Jean-Paul Cervoni; Jose M. Sanchez-Tapias; Do 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Response-guided pegylated interferon (peg-IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus-infected patients provide contradictory results. We conducted meta-analyses of randomized, controlled trials to address (1) the benefit of a 72-week extended-duration thera